New
UNE-EN ISO 10993-1:2026, assessment of the biological risk of a medical device
11/4/26
Do you know how to assess the biological risk of a medical device for people? This standard provides the guidance and requirements necessary for its assessment within a risk management process.
The objective of UNE-EN ISO 10993-1:2026 is to protect people from biological risks arising from the use of medical devices and their materials. To this end, the standard provides guidance and requirements for the biological assessment of medical devices within a risk management process.
This assessment is carried out using the finished medical device, both its components and the interaction of the product-tissue.
It considers the life cycle of the medical device from design, development and use until it is decommissioned or withdrawn from use.
UNE-EN ISO 10993-1:2026 specifies the requirements and general principles governing the biological assessment of medical devices within a risk management process, in accordance with ISO 14971 standard.
Biological assessment applies in different cases:
- A patient's body during intended use or reasonably foreseeable misuse
- The body of other users who are not patients, if the medical device is intended for personal protection such as medical gloves, surgical masks, etc.











